ArticleOncotarget2017

CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.

Aiqin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.